Abiopharma

🔍 Fu Luyang (Executive)

Company: CINCINNATI FINANCIAL CORP (CINF)

Report Date: 2026-04-29

Detailed Transactions and Holdings:

• Acquired 957 shares of Common Stock at $71.19 per share (Direct)
  Date: 2026-04-29 | Code: M | equity_swap_involved: false | shares_owned_after: 10,761.33 | transaction_form_type: 4
• Sold 147 shares of Common Stock at $163.92 per share (Direct)
  Date: 2026-04-29 | Code: F | equity_swap_involved: false | shares_owned_after: 10,670.13 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-29 | Code: H | nature_of_ownership: By 401(K) Plan | shares_owned_after: 1,010.43 | Footnotes: F2
• Sold 957 shares of Stock Option (Right to Buy) at $71.19 per share (Derivative)
  Date: 2026-04-29 | Code: M | Expires: 2028-02-09 | Exercise: 2019-02-09 | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F3, F3
• Holds 2,427 shares of Phantom Stock (Derivative)
  Date: 2026-04-29 | Code: H | shares_owned_after: 2,426.51 | Footnotes: F4, F4

Footnotes:

• F1: The reporting person is enrolled in quarterly dividend reinvestment. The beneficially owned shares have been adjusted to reflect shares purchased through the reinvestment plan.
• F2: The reported stock was acquired under the company's 401(k) plan. The reporting person may transfer the value of his shares into an alternative investment selection within the plan.
• F3: The option vests in three annual installments beginning on the first anniversary of the date of grant.
• F4: The reported phantom stock shares were acquired under the company's Top Hat Savings Plan, an "Excess Benefits Plan" within the meaning of Rule 16b-3(b)(2), and are to be settled upon the reporting person's retirement or other termination of service. The reporting person may transfer the value of his phantom stock shares into an alternative investment selection within the plan.